131 related articles for article (PubMed ID: 10380886)
21. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
[TBL] [Abstract][Full Text] [Related]
22. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
23. Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1.
Webb E; Barri G; Cory S; Adams JM
Mol Biol Med; 1989 Dec; 6(6):475-80. PubMed ID: 2699507
[TBL] [Abstract][Full Text] [Related]
24. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
25. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
26. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
27. GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.
Baron BW; Anastasi J; Bies J; Reddy PL; Joseph L; Thirman MJ; Wroblewski K; Wolff L; Baron JM
Blood Cells Mol Dis; 2014 Jan; 52(1):68-75. PubMed ID: 23910958
[TBL] [Abstract][Full Text] [Related]
28. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
Klinger MB; Guilbault B; Goulding RE; Kay RJ
Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
[TBL] [Abstract][Full Text] [Related]
29. Morphological changes of the insect cells in the baculovirus system as a function of v-myb and c-myb inserts expression and topographic localization of v-Myb and c-Myb proteins.
Stokrová J; Korb J; Dvoráková M; Cermáková V
Acta Virol; 1995 Apr; 39(2):99-108. PubMed ID: 7676943
[TBL] [Abstract][Full Text] [Related]
30. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
[TBL] [Abstract][Full Text] [Related]
31. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
32. Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene.
Cameron ER; Morton J; Johnston CJ; Irvine J; Bell M; Onions DE; Neil JC; Campbell M; Blyth K
Cell Death Differ; 2000 Jan; 7(1):80-8. PubMed ID: 10713723
[TBL] [Abstract][Full Text] [Related]
33. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
[TBL] [Abstract][Full Text] [Related]
34. The helper virus envelope glycoprotein affects the disease specificity of a recombinant murine leukemia virus carrying a v-myc oncogene.
Granger SW; Fan H
Virus Genes; 2001 Jun; 22(3):311-9. PubMed ID: 11450949
[TBL] [Abstract][Full Text] [Related]
35. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes.
Fisch P; Boehm T; Lavenir I; Larson T; Arno J; Forster A; Rabbitts TH
Oncogene; 1992 Dec; 7(12):2389-97. PubMed ID: 1461647
[TBL] [Abstract][Full Text] [Related]
36. BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line.
Bottazzi ME; Goodenow MM; Moscovici MG; Moscovici C
Oncogene; 1993 Mar; 8(3):731-6. PubMed ID: 8437856
[TBL] [Abstract][Full Text] [Related]
37. Recurring proviral integration suggests a role for proto-oncogene activation in thymomas induced with Mo-MuLV-rescued BCR/ABL virus.
Clark SS
Leukemia; 1997 Jul; 11(7):1026-33. PubMed ID: 9204986
[TBL] [Abstract][Full Text] [Related]
38. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.
Rasmussen MH; Sørensen AB; Morris DW; Dutra JC; Engelhard EK; Wang CL; Schmidt J; Pedersen FS
Virology; 2005 Jul; 337(2):353-64. PubMed ID: 15913695
[TBL] [Abstract][Full Text] [Related]
39. Transformation by v-Myb.
Lipsick JS; Wang DM
Oncogene; 1999 May; 18(19):3047-55. PubMed ID: 10378700
[TBL] [Abstract][Full Text] [Related]
40. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]